Retender radar: UK public contracts ending soon

Every contract on Find a Tender with a published end date in the future, one row per contract (lot). A contract ending is a procurement starting — unless the buyer uses a published extension option, which the row shows. Frameworks and DPS are marked: what ends there is the vehicle, not one supplier’s contract.

When contracts end · Medical equipments, pharmaceuticals
i

When contracts here run out.

Published contracts by their end date. No end date, not counted.

A likely retender, not a certain one.

902 contracts end within 24 months, 1,006 in total · £854m published GBP value, exc. VAT, in the next 24 months (framework ceilings included, not a spend forecast).

  1. Next 3 months22
  2. 3–6 months277
  3. 6–12 months292
  4. 12–24 months311

By sector, next 24 months
i

When contracts here run out.

Published contracts by their end date. No end date, not counted.

A likely retender, not a certain one.

Contracts ending in the chosen window, by category.

CPV division of the procedure; a contract with several divisions counts in each.

Contracts ending in the next 24 months

Showing 376–390

  1. Ends · in 230 daysFramework re-letExtension option · up to 31 May 2029Panel · 14 suppliers

    Lot 1 - CM/PHS/25/5728/01

    NHS England · Central government · Nationwide (UK), North East England, North West England, Yorkshire and the Humber, East Midlands, West Midlands

    Panel: Abbvie Ltd, Alimera Sciences, Bayer Plc +11 more

    • Pharmaceutical products
    • Various medicinal products
    Contract value
    £689mceiling for the whole framework
    Annual run-rate
    —panel, not one supplier
    Term
    1 Dec 2025 → 31 May 2027 · 1.4 yrs · up to 31 May 2029 with extensions
    Reference
    ocds-h6vhtk-055064
  2. Ends · in 230 daysFramework re-letExtension option · up to 31 Jan 2030Panel · 21 suppliers

    NHS National Framework for Generics Housekeeping Lot 1 - Oral Products

    NHS England · Central government · North East England, North West England, Yorkshire and the Humber, East Midlands, West Midlands, East of England

    Panel: ACCORD-UK LTD, Alissa Healthcare Research Limited, Brown and Burk UK Ltd +18 more

    • Pharmaceutical products
    Contract value
    £18mceiling for the whole framework
    Annual run-rate
    —panel, not one supplier
    Term
    1 Feb 2026 → 31 May 2027 · 1.3 yrs · up to 31 Jan 2030 with extensions
    Reference
    ocds-h6vhtk-058823
  3. Ends · in 230 daysFramework re-letExtension option · up to 31 May 2028Panel · 16 suppliers

    Lot 1 - CM/PHG/23/5699/01 Oral (plus non-parenteral) products

    NHS England · Central government · North East England, North West England, Yorkshire and the Humber, East Midlands, West Midlands, East of England

    Panel: Amarox Limited, Brown and Burk UK Ltd, Celix Pharma Ltd. +13 more

    • Pharmaceutical products
    Contract value
    £18mceiling for the whole framework
    Annual run-rate
    —panel, not one supplier
    Term
    1 Jun 2026 → 31 May 2027 · 11 months · up to 31 May 2028 with extensions
    Reference
    ocds-h6vhtk-05193a
  4. Ends · in 230 daysFramework re-letPanel · 29 suppliers

    Lot 1.2 - Technology Enabled Care (Telecare) services

    ESPO · Nationwide (UK)

    Panel: Alcove Limited, Appello Smart Living Solutions, BDS (Northern) Ltd t/a BDS Recruitment +26 more

    • Alarm-monitoring services
    • Health and social work services
    • Installation services of communications equipment
    Contract value
    £8.8mceiling for the whole framework
    Annual run-rate
    —panel, not one supplier
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-04c625
  5. Ends · in 230 daysFramework re-letPanel · 22 suppliers

    Lot 1.1 - Technology Enabled Care (Telecare) products and associated services

    ESPO · Nationwide (UK)

    Panel: Access UK Ltd, Alcove Limited, Alertacall Limited +19 more

    • Alarm-monitoring services
    • Health and social work services
    • Installation services of communications equipment
    Contract value
    £5.6mceiling for the whole framework
    Annual run-rate
    —panel, not one supplier
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-04c625
  6. Ends · in 230 daysFramework re-letPanel · 13 suppliers

    Lot 2.1 - Telehealth products and associated services

    ESPO · Nationwide (UK)

    Panel: Abilia Ltd, Baywater Healthcare UK Limited, Broomwell Healthwatch Limited +10 more

    • Alarm-monitoring services
    • Health and social work services
    • Installation services of communications equipment
    Contract value
    £800kceiling for the whole framework
    Annual run-rate
    —panel, not one supplier
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-04c625
  7. Ends · in 230 daysFramework re-letPanel · 16 suppliers

    Lot 2.2 - Telehealth services

    ESPO · Nationwide (UK)

    Panel: Baywater Healthcare UK Limited, Broomwell Healthwatch Limited, EVONDOS OY +13 more

    • Alarm-monitoring services
    • Health and social work services
    • Installation services of communications equipment
    Contract value
    £800kceiling for the whole framework
    Annual run-rate
    —panel, not one supplier
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-04c625
  8. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Milpharm Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  9. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Roma Pharmaceuticals Limited

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  10. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Perennial Pharma Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  11. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Consilient Health Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  12. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Pfizer Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  13. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Rosemont Pharmaceuticals Ltd

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  14. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: GLAXOSMITHKLINE UK LIMITED

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
  15. Ends · in 230 daysFramework re-let

    Wave 14c - Orals (plus non-parenteral) Products (all regions)

    NHS England · NHS & health · Nationwide (UK)

    Incumbent: Aventis Pharma Ltd Trading As Sanofi

    • Pharmaceutical products
    Contract value
    £1ceiling for the whole framework
    Annual run-rate
    —ceiling, not a run-rate
    Term
    Ends 31 May 2027 · start not published
    Reference
    ocds-h6vhtk-040d4d
How to read the radar
  • End date is the contract period end the buyer published on Find a Tender. Contracts without an end date are not on the radar.
  • Extension option means the notice publishes a renewal or option clause; the buyer may extend instead of retendering. Hide them to see contracts that must be re-procured.
  • Incumbent is the canonical supplier on the award behind the contract. A panel (several suppliers on one award) is shown as a panel — no single incumbent is invented.
  • Annual run-rate = published GBP value ÷ published term, only for a single supplier, a term of six months or more and a plain contract (not a framework or DPS ceiling).
  • Counts are exact from the nightly projection when you filter by horizon and sector only; any other filter shows a bounded total — exact up to 1,000 contracts, an honest “1,000+” floor above that.